Comparisons with standard susceptible insects showed that a strain of Tribolium castaneum, with a specific resistance to malathion and its carboxylic ester analogues, had no cross‐resistance to topical applications of natural pyrethrins. Another strain of T. castaneum, showing resistance to many organophosphorus (OP) insecticides, was cross‐resistant to pyrethrins ( × 34) and eight synthetic pyrethroids also applied topically; least cross‐resistance occurred with resmethrin ( × 2.2), bioresmethrin ( × 3.3) and phenothrin ( × 4.0). Generally larger resistance factors were recorded with formulations synergised by piperonyl butoxide (PB). The greatest cross‐resistance encountered was with unsynergised tetramethrin ( × 338). Apart from tetramethrin, factors of synergism did not exceed 5.7 with either the susceptible or multi‐OP resistant strains. PB antagonised six of the nine pyrethroids against the multi‐OP resistant strain. Antagonism also occurred with two of these six, permethrin (cis: trans ratio 1:3) and 5‐prop‐2‐ynylfurfuryl ( 1RS)‐cis,trans‐chrysanthemate (‘Prothrin’), against the susceptible strain. Considering only formulations without the synergist, the most effective compounds against the susceptible strain, relative to pyrethrins, were bioresmethrin (2.7) and permethrin (2.4). Similarly with the multi‐OP resistant strain the most effective compounds were bioresmethrin (28), resmethrin (14) and permethrin (6.6). Thus the LD50 (the dose required to kill 50% of the test species) for bioresmethrin against the resistant strain (0.14 μg) only slightly exceeded the LD50 for pyrethrins against the susceptible strain (0.12 μg).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.